Letter to eligible shareholders
Released
Released
Announcement PDF
14 May 2025
Dear Shareholder
Notice to Eligible Shareholders of Loyalty Options Offer
We write to you as the registered holder of fully paid ordinary shares (Shares) in Percheron Therapeutics
Limited (ACN 095 060 745) (ASX:PER) (Company) as at 7.00pm (AEST) Tuesday, 13 May 2025 (Record Date).
As announced on 7 May 2025, the Company is undertaking a non-renounceable pro-rata bonus offer of 1
unquoted option (Loyalty Option) for every 10 Shares held by Eligible Shareholders on the Record Date
(Offer). Each Loyalty Option will have an exercise price of $0.035 and expire on the date that is 3 years from
the date of issue. The Loyalty Options will be issued for nil consideration to incentivise Eligible Shareholders
for their ongoing support and engagement and provide them with a greater opportunity to participate in the
potential future success of the Company.
You have been deemed to be an Eligible Shareholder for the purposes of the Entitlement Offer to receive 1
Loyalty Option for every 10 Shares you hold (Entitlement). Fractional entitlements will be rounded down to
the nearest whole number.
A prospectus in relation to the Offer was lodged with ASIC on 6 May 2025 and ASX on 7 May 2025
(Prospectus).
Capitalised terms used, but not defined, in this letter have the meaning ascribed to them in the Prospectus.
Details of the Offer
Shareholders who are eligible to participate in the Entitlement Offer (Eligible Shareholders) are
shareholders who as at the Record Date:
•
are registered as a holder of Shares; and
•
have a registered address in Australia or subject to the offer restrictions in Section 2.18 of the
Prospectus, New Zealand, Singapore, or Hong Kong.
The Offer is non-renounceable, meaning that Eligible Shareholders will not be able to transfer their
Entitlements pursuant to the Offer.
The Loyalty Options are being issued for nil consideration. Accordingly, no funds will be raised pursuant to
the Offer.
It is important that you read the Prospectus carefully and in its entirety. You should seek advice from your
suitably qualified professional adviser if you have any queries.
If you are an Eligible Shareholder, no action is required from you to take up your Entitlement under the Offer.
L30, Collin s Pla ce, 35 Collin s Street, Melb ourn e, VIC 3000, Aus tra lia
E: in fo@Perch eron T x . co m ■ T : +61 3 9827 8999
www.Per ch er o nT x. c om
How to access the Offer and Prospectus
1. ONLINE – the Offer and Prospectus can be accessed via the Company’s website:
https://percherontx.com/investors/asx-announcements/.
2. PAPER – request a paper copy of the Prospectus (free of charge) from the Company’s registered
office by contacting the Company.
Purpose of Offer
The purpose of the Offer is to reward the loyalty of Eligible Shareholders who hold Shares as at the Record
Date.
The Prospectus has also been issued to facilitate secondary trading of the Shares to be issued upon exercise
of the Loyalty Options to be issued under the Offer.
Issuing the Loyalty Options under the Prospectus will enable persons who are issued the Loyalty Options to
on-sell the Shares issued on exercise of the Loyalty Options pursuant to ASIC Corporations (Sale Offers That
Do Not Need Disclosure) Instrument 2016/80.
Indicative Timetable
Event
Lodgement of this Prospectus with ASIC
Lodgement of Appendix 3B and Prospectus with ASX
Announcement of Offer
Ex date
Record Date for the Offer
Date (2025)*
(Australian Eastern Standard
Time)
Tuesday, 6 May
Wednesday, 7 May
Monday, 12 May
7.00pm on
Tuesday, 13 May
Wednesday, 14 May
Tuesday, 20 May
Dispatch of Letters to Eligible and Ineligible Shareholders
Issue of Loyalty Options
Lodgement of Appendix 3G with ASX
Dispatch of holding statements
Wednesday, 21 May
All dates (other than those which have occurred as at the date of this letter) are indicative only. The Company
retains the discretion, subject to the ASX Listing Rules and the Corporations Act, to alter key dates at its
discretion (generally or in particular cases), without prior notice.
Further information
For further information on the Offer you may contact the Company Secretary by email at
deborah.ambrosini@percherontx.com. For all general shareholder enquiries, please contact the Company's
Share Registry Boardroom Pty Limited on 1300 737 760 (within Australia) or +61 2 9290 9600 (outside
Australia).
Yours faithfully
Dr Charmaine Gittleson
Non-Executive Chair
Percheron Therapeutics Limited
Page 2 of 2
Share your feedback
Discover